Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway

Documenti analoghi

• When Less Is More, None Can Be Even Better: Rethinking Routine Follow‐Up of Chronic Disease Exemplified With Rheumatoid Arthritis
  di: Alen Brkic, et al.
  Pubblicazione: (2025)
• Associations of Lifestyle‐Related Factors and Psoriatic Arthritis Disease Activity: The Dutch South West Psoriatic Arthritis Study
  di: Batoul Hojeij, et al.
  Pubblicazione: (2026)
• Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease
  di: Catherine Howe, et al.
  Pubblicazione: (2025)
• The Inflation Reduction Act and Etanercept
  di: Charles L. Bennett, et al.
  Pubblicazione: (2025)
• Development of Extramusculoskeletal Manifestations in Upadacitinib‐Treated Patients With Psoriatic Arthritis or Axial Spondyloarthritis
  di: Denis Poddubnyy, et al.
  Pubblicazione: (2025)